How to Help Your Patients Find Entecavir in Stock: A Provider's Guide

It's an increasingly common scenario in hepatology and gastroenterology practices: a patient calls your office because their pharmacy is out of entecavir. They're worried, and they should be—stopping hepatitis B treatment carries real clinical risk. As their provider, how you respond matters.

This guide gives you concrete steps and tools to help your patients find entecavir in stock quickly, and how to build proactive systems in your practice to prevent the problem before it occurs.

Why This Matters: The Clinical Stakes of an Entecavir Stockout

The FDA boxed warning for entecavir is unambiguous: severe acute exacerbations of hepatitis B have been reported in patients who discontinued anti-HBV therapy. Your patients need to understand—and you need to reinforce—that running out of medication is not an option they can simply wait out.

In your clinical practice, a patient calling about a stockout should be triaged as an urgent matter. Your response protocol should be clear and accessible to your clinical team.

Step 1: Determine How Much Medication the Patient Has Left

When a patient contacts your practice about a fill problem, the first question is: how many days' supply remain? This determines urgency:

• >7 days remaining: Time to locate an alternative pharmacy. Direct patient to medfinder and pharmacy search resources.
• 3–7 days remaining: Urgent. Call preferred specialty pharmacies directly. Consider whether you have office samples available.
• <3 days remaining: Emergency. Provide samples if available. Consider same-day switch to TDF or TAF if stocked locally. Monitor LFTs closely.

Step 2: Refer Patients to Specialty Pharmacies

Specialty pharmacies typically maintain more consistent stock of entecavir than general retail pharmacies. Maintain a short list of 2–3 specialty pharmacies in your area that reliably carry entecavir. Options include:

• Walgreens Specialty Pharmacy
• CVS Specialty
• Accredo (Express Scripts)
• Diplomat Specialty Pharmacy (Optum)
• Your regional health system's outpatient pharmacy

Step 3: Recommend medfinder to Your Patients

medfinder is a service patients can use to find their medication in stock. After entering their medication, dosage, and zip code, medfinder calls nearby pharmacies and texts the patient with results—which ones have it and can fill the prescription. This removes the burden of phone calls from both the patient and your staff. Learn more at medfinder.com/providers.

Step 4: Issue 90-Day Prescriptions Going Forward

One of the most practical things prescribers can do to prevent future stockout crises is to routinely prescribe 90-day supplies of entecavir rather than 30-day supplies. This reduces the number of times per year a patient must successfully refill—and gives more lead time to find an alternative source if needed. Most commercial insurers and Medicare allow 90-day mail-order fills for maintenance medications.

Step 5: Address Financial Barriers Proactively

Cost can drive non-adherence even when medication is technically available. At high retail prices (over $1,100 for 30 tablets without insurance), entecavir is unaffordable without coverage or a discount card. Key resources to share with patients:

• GoodRx: Free discount card; generic entecavir as low as $13–$31 per 30-count fill
• SingleCare: Generic entecavir as low as $11.06 per 30-count fill
• Good Days Patient Assistance Program: 1-877-968-7233; mygooddays.org — requires insurance and qualifying HBV diagnosis

Building a Proactive Protocol in Your Practice

To prevent the crisis-management mode, consider implementing these practice-level changes:

1. At every visit, confirm the patient has a current prescription and knows where to fill it
2. Include entecavir access information in your new HBV patient education handout
3. Maintain a standing protocol for medication access emergencies (who calls the patient back, which pharmacies to try first)
4. Keep a small stock of samples for bridging situations

For deeper background on the current supply landscape, see our related post: Entecavir Shortage: What Providers and Prescribers Need to Know in 2026.